More on COGT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $9.58 |
|
|||
| Open | $9.53 | ||||
| 52 Wk High | $5.57 | ||||
| 52 Wk Low | $2.90 | ||||
| Day High | $9.75 | ||||
| Day Low | $9.27 | ||||
| P/E | 43.23 | ||||
| EPS | $0.22 | ||||
| Volume | 945,708 | ||||
- Piper Sandler Reiterates Overweight Rating on Cogent (COGT)
- Form SC 13G/A Cogent Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
- Form SC 13G/A Cogent Biosciences, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P.
- Form SC 13G/A Cogent Biosciences, Inc. Filed by: COMMODORE CAPITAL LP
- Form SC 13G/A Cogent Biosciences, Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
- Form SC 13G/A Cogent Biosciences, Inc. Filed by: Kynam Capital Management, LP
- Cogent (COGT) PT Lowered to $15 at Needham
- Form 10-Q Cogent Biosciences, Inc. For: Sep 30
- Form 8-K Cogent Biosciences, Inc. For: Nov 12
- Cogint (COGT) Misses Q3 EPS by 7c
Entities mentioned with COGT
- Twitter | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Jefferies & Co | View Related Stories »
- Definitive Agreement | View Related Stories »
- S3 | View Related Stories »
- JPMorgan | View Related Stories »
- 3M/Cogent | View Related Stories »
- Show More...
